Agios Pharmaceuticals | AGIO - 流动负债



金融业
股票价格
USD
资产
USD 1.11B
现金及等价物
USD 99.65M
销售成本
USD 1.32M
流动资产
USD 717.67M
流动负债
USD 70.22M
债务
USD 35.75M
EBIT
USD -110.03M
EBITDA
USD -108.66M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.03B
销售毛利
USD 19.43M
债务利息支出
USD 1.11B
利息收入
USD 10.8M
贷款资金
USD 1.06M
市值
USD 1.89B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 44.74M
销售和管理费用
USD 38.46M
股票
USD 35.75M
贸易债权人
USD 16.35M
应收帐款人
USD 16.13M


流动负债 更改 日
AbbVie USD 41.64B 458M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Astellas Pharma JPY 1.23T 16.36B 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 31.75B 374M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06